KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 123 filers reported holding KEROS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $18,289,780 | -56.3% | 400,214 | -36.7% | 0.01% | -53.8% |
| Q1 2024 | $41,841,644 | +50.5% | 632,049 | -9.6% | 0.01% | 0.0% |
| Q4 2023 | $27,809,138 | +84.5% | 699,425 | +47.9% | 0.01% | +62.5% |
| Q3 2023 | $15,071,302 | -20.7% | 472,751 | 0.0% | 0.01% | -11.1% |
| Q2 2023 | $18,995,136 | -5.9% | 472,751 | 0.0% | 0.01% | -10.0% |
| Q1 2023 | $20,186,468 | -11.1% | 472,751 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $22,701,503 | +27.6% | 472,751 | -0.1% | 0.01% | +20.0% |
| Q3 2022 | $17,794,000 | +36.2% | 472,998 | +0.0% | 0.01% | +66.7% |
| Q2 2022 | $13,066,000 | -39.1% | 472,880 | +19.8% | 0.01% | -33.3% |
| Q1 2022 | $21,463,000 | -7.1% | 394,677 | -0.0% | 0.01% | +12.5% |
| Q4 2021 | $23,094,000 | +47.9% | 394,688 | +0.0% | 0.01% | +33.3% |
| Q3 2021 | $15,613,000 | -6.9% | 394,660 | -0.0% | 0.01% | 0.0% |
| Q2 2021 | $16,764,000 | +4.7% | 394,725 | +51.7% | 0.01% | -14.3% |
| Q1 2021 | $16,014,000 | -12.7% | 260,179 | +0.0% | 0.01% | -12.5% |
| Q4 2020 | $18,349,000 | – | 260,126 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 292,833 | $17,134,000 | 5.65% |
| Deep Track Capital, LP | 1,300,000 | $76,063,000 | 5.37% |
| Octagon Capital Advisors LP | 340,214 | $19,906,000 | 3.87% |
| Opaleye Management Inc. | 265,750 | $15,549,000 | 3.30% |
| First Light Asset Management, LLC | 552,098 | $32,303,000 | 2.31% |
| Altium Capital Management LP | 116,000 | $6,787,000 | 1.87% |
| Nantahala Capital Management | 796,698 | $46,615,000 | 1.64% |
| Orbimed Advisors | 1,679,417 | $98,263,000 | 1.26% |
| Darwin Global Management, Ltd. | 111,500 | $6,524,000 | 1.00% |
| Parkman Healthcare Partners LLC | 69,861 | $4,088,000 | 0.90% |